Immuron Ltd (NASDAQ:IMRN) was held by 6 institutional investors that filed 13F reports for the quarter ended June 30, 2026.
Collectively, these holders controlled 0.97% of Immuron's outstanding shares in Q2 2026, down from 1.45% in Q1 2026.
Total shares held in IMRN fell 7.69% from Q1 2026; the number of holders rose 50.00% from Q2 2025.
Of these 6 holders, 4 added to their positions, 1 reduced its stake and 1 left its position unchanged.
Combined, institutional investors held 78.34K shares of IMRN as of Q2 2026, down 6.52K from the prior quarter and up 55.99K from a year earlier.
Citadel Advisors LLC held the largest position in IMRN at 43.12K shares as of June 30, 2026, or 0.53% of shares outstanding.
Holders that added the most shares of Immuron in Q2 2026 were Citadel Advisors LLC (+29.32K shares) and BNP Paribas Financial Markets (+600 shares).
The largest position reduction in IMRN for Q2 2026 was by Morgan Stanley (-28.87K shares).
According to Business Quant data, the leading holders of IMRN for Q2 2026 were Citadel Advisors LLC (43.12K shares), HRT Financial LP (20.58K shares), Rhumbline Advisers (7.37K shares), BNP Paribas Financial Markets (5.2K shares), Morgan Stanley (1.7K shares) and UBS Group AG (363 shares).